Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03067467 · ClinicalTrials.gov registry record
Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)
A clinical trial of Brain Tumor Adult, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT03067467: Recruiting study of Brain Tumor Adult, sponsored by University of Texas Southwestern Medical Center.
NCT03067467 is a study of Brain Tumor Adult that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 25 participants, below the 75-participant average among 6 other Brain Tumor Adult trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03067467, a study of Brain Tumor Adult, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a non-randomized, purely observational, feasibility study to detect metabolic changes in patients with brain malignancy using a novel hyperpolarized \[1-13C\]pyruvate MRSI.
Primary Outcome
Measurement of the ratio of metabolic products, \[1-13C\]lactate and 13C-bicarbonate, from hyperpolarized \[1-13C\]pyruvate will be used as an index of metabolic balance between glycolytic pathway and mitochondrial oxidative phosphorylation.
Conditions Studied
Interventions
- DRUG Hyperpolarized 13C-Pyruvate
- DRUG Gadolinium
Study Locations (1)
Texas
- UT Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-06-01 |
| Est. Completion | 2026-12-31 |
What NCT03067467 shows while recruiting
NCT03067467 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 75-participant average among 6 other Brain Tumor Adult trials with a reported enrollment target (67% lower).
The record links to 1 condition, with Brain Tumor Adult appearing as the primary indexed condition, and to 2 interventions - of which Hyperpolarized 13C-Pyruvate is the first listed.
NCT03067467 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03067467 about?
NCT03067467 is a clinical study titled "Metabolic Characteristics of Brain Tumors Using Hyperpolarized Carbon-13 Magnetic Resonance Spectroscopic Imaging (MRSI)". This is a non-randomized, purely observational, feasibility study to detect metabolic changes in patients with brain malignancy using a novel hyperpolarized \[1-13C\]pyruvate MRSI.
What is the current status of trial NCT03067467?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2019-06-01. Estimated completion is 2026-12-31.
What conditions does trial NCT03067467 study?
This clinical trial studies the following conditions: Brain Tumor Adult.
What interventions are being tested in trial NCT03067467?
The interventions under investigation include: Hyperpolarized 13C-Pyruvate (DRUG), Gadolinium (DRUG).
Who is sponsoring clinical trial NCT03067467?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03067467 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain Tumor Adult
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
-
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
RECRUITING · Phase 1
-
Evaluation of the Efficacy of STRATAFIX for Neurosurgical Cranial and Spine Procedures
RECRUITING · Phase 4
-
A Study of Cognitive Changes in Patients Receiving Brain Radiation
ACTIVE NOT RECRUITING
-
Novel Gamma-Delta (γδ)T Cell Therapy for Treatment of Patients With Newly Diagnosed Glioblastoma
ACTIVE NOT RECRUITING · Phase 1
-
Safety and Feasibility of Preoperative and Intraoperative Image-Guided Resection of Gliomas
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI